Your browser is no longer supported. Please, upgrade your browser.
Settings
VVOS [NASD]
Vivos Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.80 Insider Own0.10% Shs Outstand20.74M Perf Week-10.84%
Market Cap113.08M Forward P/E- EPS next Y-0.65 Insider Trans33.13% Shs Float17.84M Perf Month37.54%
Income-15.50M PEG- EPS next Q-0.18 Inst Own10.10% Short Float3.66% Perf Quarter-5.06%
Sales14.50M P/S7.80 EPS this Y-7.70% Inst Trans157.38% Short Ratio0.19 Perf Half Y-32.52%
Book/sh1.76 P/B2.66 EPS next Y14.50% ROA-60.80% Target Price- Perf Year-
Cash/sh1.42 P/C3.31 EPS next 5Y- ROE-101.90% 52W Range2.61 - 14.41 Perf YTD-20.64%
Dividend- P/FCF- EPS past 5Y- ROI-66.20% 52W High-67.45% Beta-
Dividend %- Quick Ratio4.20 Sales past 5Y- Gross Margin79.70% 52W Low79.69% ATR0.55
Employees93 Current Ratio4.20 Sales Q/Q-30.80% Oper. Margin- RSI (14)49.70 Volatility8.12% 11.41%
OptionableYes Debt/Eq0.04 EPS Q/Q13.80% Profit Margin- Rel Volume0.21 Prev Close4.65
ShortableYes LT Debt/Eq0.00 EarningsAug 12 AMC Payout- Avg Volume3.37M Price4.69
Recom2.00 SMA20-7.26% SMA5013.13% SMA200-23.33% Volume702,283 Change0.86%
Sep-08-21 07:30AM  
Aug-26-21 09:08AM  
07:30AM  
Aug-24-21 10:13AM  
Aug-23-21 02:44PM  
11:17AM  
09:27AM  
08:36AM  
07:57AM  
07:30AM  
07:15AM  
Aug-17-21 04:05PM  
Aug-12-21 04:05PM  
Aug-09-21 04:05PM  
08:00AM  
Jul-29-21 08:00AM  
Jul-13-21 08:00AM  
Jul-07-21 08:00AM  
Jun-15-21 06:41AM  
May-26-21 08:00AM  
May-17-21 04:05PM  
03:15PM  
May-14-21 07:27AM  
May-13-21 08:00AM  
May-11-21 04:29PM  
May-06-21 09:41PM  
Apr-15-21 10:54AM  
Apr-14-21 09:15AM  
Apr-12-21 08:00AM  
06:00AM  
Apr-09-21 06:16AM  
Mar-30-21 08:00AM  
Mar-25-21 04:05PM  
03:15PM  
Mar-22-21 04:05PM  
Mar-18-21 08:00AM  
Mar-11-21 07:55AM  
Mar-08-21 08:00AM  
Mar-01-21 08:00AM  
Feb-16-21 08:00AM  
Feb-02-21 08:00AM  
Jan-29-21 08:00AM  
Jan-06-21 08:00AM  
Dec-28-20 11:26AM  
Dec-17-20 12:23PM  
Dec-15-20 05:18PM  
Dec-11-20 05:39PM  
05:25PM  
05:23PM  
Vivos Therapeutics, Inc., a medical technology company, engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing, such as mild-to-moderate obstructive sleep apnea (OSA). Its treatment, the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of mild to moderate OSA. Vivos Therapeutics also offers VivoScore, a comprehensive home sleep apnea test. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Huntsman Ronald KirkChief Executive OfficerAug 17Buy3.005,00015,00010,500Aug 18 03:47 PM
Amman Bradford K.Chief Financial OfficerMay 25Buy5.291,0005,2902,000May 25 09:45 PM
Amman Bradford K.Chief Financial OfficerDec 24Buy7.381,0007,3801,000Dec 28 06:21 AM
Huntsman Ronald KirkChief Executive OfficerDec 23Buy7.271,0007,2671,500Dec 23 06:53 PM